Skip to main content

Table 2 Comparison between Vildagliptin and Metformin on vascular reactivity (intergroup and intragroup analysis)

From: 30-days effects of vildagliptin on vascular function, plasma viscosity, inflammation, oxidative stress, and intestinal peptides on drug-naïve women with diabetes and obesity: a randomized head-to-head metformin-controlled study

 

Vildagliptin (day 0)

Vildagliptin (day 30)

Metformin (day 0)

Metformin (day 30)

Resting FCD (cap/mm2)

24.1 ± 15.65

32 ± 14.69

34.64 ± 20.29

43.61 ± 16.33

FCD during PORH (cap/mm2)

20.81 ± 14.72

28.97 ± 13.01

32.40 ± 19.41

45.75 ± 15.98 &

  1. Data are expressed as mean ± SD
  2. FCD functional capillary density, PORH post-occlusive reactive hyperemia
  3. Intergroup comparisons: &P < 0.05
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us